Emergence of Difficult-to-Treat Tinea Corporis Caused by Trichophyton mentagrophytes Complex Isolates, Paris, France
Sarah Dellière
1 , Brune Joannard
1, Mazouz Benderdouche, Anselme Mingui, Maud Gits-Muselli, Samia Hamane, Alexandre Alanio, Antoine Petit, Germaine Gabison, Martine Bagot, and Stéphane Bretagne
Author affiliations: Hôpital Saint Louis Laboratoire de Parasitologie-Mycologie, Assistance Publique des Hôpitaux de Paris, Paris, France (S. Dellière, B. Joannard, M. Benderdouche, A. Mingui, M. Gits-Muselli, S. Hamane, A. Alanio, S. Bretagne); Université de Paris, Paris (S. Dellière, M. Gits-Muselli, A. Alanio, M. Bagot, S. Bretagne); Centre National de Référence Mycoses Invasives et Antifongiques Unité de Mycologie Moléculaire, Paris (A. Alanio, S. Bretagne); Hôpital Saint-Louis Service de Dermatologie, Assistance Publique des Hôpitaux de Paris, Paris (A. Petit, G. Gabison, M. Bagot); INSERM U976 (M. Bagot)
Main Article
Figure 1
Figure 1. Morphologic features of difficult-to-treat dermatophytosis caused by Trichophyton mentagrophytes complex internal transcribed spacer type VIII (T. indotineae) in patients in Paris, France. A) Scaly plaques with erythema and surrounding papulae and vesicles of the arms (patient 1); B) centrifuge annular erythema of the trunk after topical and oral corticosteroids (patient 6); C) erythematous and scaly plaques (patient 3); D) pruritic cutaneous lesions of the groin and axillary pits to which was applied steroids (patient 5).
Main Article
Page created: December 08, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.